These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3178598)

  • 21. Postoperative malignant hyperthermia and dantrolene therapy.
    Schulte-Sasse U; Hess W; Eberlein HJ
    Can Anaesth Soc J; 1983 Nov; 30(6):635-40. PubMed ID: 6640400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dantrolene sodium and management of malignant hyperthermia.
    Fuerst DL; Toth AJ
    AANA J; 1983 Aug; 51(4):406-10. PubMed ID: 6556878
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant hyperthermia in an office surgery suite: a case report.
    Turpin IM; Manino J
    Aesthetic Plast Surg; 1989; 13(2):121-3. PubMed ID: 2741752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia: clinical course and metabolic changes in two patients.
    Rutberg H; Håkanson E
    Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
    Inada H; Jinno S; Kohase H; Fukayama H; Umino M
    Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens].
    Hoffmann-Lundgren B; Kühn K; Hausdörfer J
    Anasth Intensivther Notfallmed; 1982 Jun; 17(3):169-70. PubMed ID: 7125160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant hyperpyrexia: an update for the otolaryngologist.
    Schvaneveldt JA; Stankiewicz JA
    Laryngoscope; 1981 Jun; 91(6):918-26. PubMed ID: 7242187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sodium dantrolene in the treatment of malignant hyperthermia].
    Ording HO
    Ugeskr Laeger; 1981 Sep; 143(38):2423-4. PubMed ID: 7303262
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of malignant hyperthermia?
    Broekema AA; Boersma GA; Hennis PJ
    Anaesthesia; 1991 Nov; 46(11):942-5. PubMed ID: 1750596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
    Noda B; Higa K; Naitoh H; Dan K
    Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    Magistris F; Gamble J
    A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [S1 guidelines on malignant hyperthermia : Update 2018].
    Wappler F
    Anaesthesist; 2018 Jul; 67(7):529-532. PubMed ID: 29943228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dantrolene sodium approved for malignant hyperthermia.
    FDA Drug Bull; 1979 Nov; 9(5):27. PubMed ID: 510837
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant hyperpyrexia.
    Rosenburg H
    Am J Nurs; 1981 Aug; 81(8):1484-6. PubMed ID: 6910989
    [No Abstract]   [Full Text] [Related]  

  • 37. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant hyperthermia: biochemico-metabolic aspects and personal experiences].
    Di Prospero S; Bianchi S; Di Lazzaro M; Camilli-Giammei T
    Clin Ter; 1984 Sep; 110(6):549-53. PubMed ID: 6238769
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
    Abballe C; Primieri P; De Cosmo G
    Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of malignant hyperthermia with dantrolene].
    Landauer B
    Anaesthesist; 1980 Sep; 29(9):507-8. PubMed ID: 7468992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.